市场调查报告书
商品编码
1439709
全球消融设备市场:洞察、竞争格局、市场预测:2030 年Ablation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
预计 2024 年至 2030 年期间,全球消融设备市场规模将以 11.65% 的复合年增长率扩大。 癌症(包括肝癌)发生率上升;慢性疼痛(包括肌肉骨骼疼痛)盛行率上升;心律不整(包括心房颤动)盛行率上升;因素包括认可度增加。 因此,预计在 2024 年至 2030 年的预测期内,消融设备市场将以显着的复合年增长率成长。
推动消融设备需求的最突出因素之一是各种癌症(包括肝癌)发生率的增加。 根据美国疾病管制与预防中心(CDC)2023年发布的数据,美国每年约有25,000名男性和11,000名女性罹患肝癌。 因此,消融装置可透过破坏肝臟肿瘤来治疗肝癌,这将增加对消融装置的需求,从而增加预测期内消融装置市场的整体成长。
消融装置普及的另一个主要因素是慢性疼痛(包括肌肉骨骼疼痛)盛行率的上升。 根据世界卫生组织 (WHO) 2023 年发布的最新数据,肌肉骨骼疼痛影响全球约 17.1 亿人。 此外,根据上述来源和统计数据,在肌肉骨骼疾病患者中,腰痛是最常见的肌肉骨骼疾病,影响全球 5.68 亿人。 因此,需要消融设备来控制与肌肉骨骼疾病相关的疼痛,这可能会增加对消融设备的需求,从而推动消融设备的整体市场成长。
本报告研究了全球消融设备市场,并提供了市场概述,包括按技术、应用、最终用户、地区和参与市场的公司概况划分的趋势。
Ablation Devices Market By Technology (Radiofrequency, Thermosphere, Microwave, Cryoablation, Ultrasonic, And Others), By Application (Cardiovascular, Oncology, Gynaecology, Orthopaedic, And Others), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), And by geography is estimated to grow at an appreciable CAGR forecast till 2030 owing to the increasing incidence of various cancers and the rising prevalence of chronic pains such as musculoskeletal pains
The global ablation devices market is estimated to grow at a CAGR of 11.65% during the forecast period from 2024 to 2030. Factors such as the increasing incidence of cancers such as liver cancer, the rising prevalence of chronic pains such as musculoskeletal pains, the rising prevalence of cardiac arrhythmia such as atrial fibrillation, and the rising regulatory approvals for technologically advanced ablation devices. Therefore, the market for ablation devices is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.
Ablation Devices Market Dynamics:
One of the most prominent factors driving the demand for ablation devices is the increasing incidence of various cancers such as liver cancer. According to the Centers for Disease Control and Prevention (CDC) published data in the year 2023, each year in the United States, around 25,000 men and 11,000 women suffer from liver cancer. Therefore, ablation devices can be used for the treatment of liver cancer by destroying liver tumors, this will increase the demand for ablation devices, thereby increasing the growth of the overall ablation devices market growth during the forecast period (2024-2030).
Another key contributor to the growing popularity of ablation devices is the rising prevalence of chronic pains such as musculoskeletal pains. As per the latest data available from World Health Organization (WHO) data published in the year 2023, musculoskeletal pains affect approximately 1.71 billion people in the world. Further, among people with musculoskeletal disorders, lower back pain is the most common musculoskeletal condition, affecting 568 million people worldwide, as per the above-mentioned source and statistics. Therefore, ablation devices are needed to limit the pains related to musculoskeletal conditions, which could boost the demand for ablation devices, thereby driving the ablation device's overall market growth.
Therefore, all the factors mentioned above will collectively surge the growth of the ablation devices market during the forecast period from 2024-2030.
However, the risks associated with ablation procedures such as bleeding, infections, blood clots, and the stringent regulatory approvals for ablation devices may prove to be restraining factors to the ablation devices market growth.
Additionally, the ongoing COVID-19 pandemic has negatively impacted the ablation devices market. The nationwide lockdown in almost every country, restricted the movement of people, supply chains & logistics were halted, unavailability of the workforce at the production sites hampered the manufacturing process due to which there was product shortage in the market, and elective surgeries were also postponed and not given priority as COVID-19 patients were given more preference in terms of treatment. Ablation procedures are the treatment options used in elective surgeries such as cardiovascular, cancers, and other surgeries which were also postponed. For instance, as per the American Hospital Association 2020, between March and June 2020, there had been an estimated loss of USD 50.7 billion to United States hospitals as a result of the reduction observed in "elective" procedures. As per the same source, on average these procedures accounted for about 31% of the net revenue in the United States. However, with masses being vaccinated, relaxation in lockdown restrictions, resumption of supply chains, logistics, & manufacturing units, and an increase in elective surgeries, the ablation devices market has picked momentum again and is expected to further grow during the forecast period (2024-2030)
Ablation Devices Market Segment Analysis:
Ablation Devices Market by Technology (Radiofrequency, Thermosphere, Microwave, Cryoablation, Ultrasonic, and Others), Application (Cardiovascular, Oncology, Gynaecology, Orthopaedic, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the technology segment of the ablation devices market, radiofrequency ablation technology is expected to hold a significant revenue share in the year 2023. This can be ascribed to the advantages associated with radiofrequency ablation technology over other ablation technologies. Radiofrequency ablation technology is a minimally invasive technology and promises long-term survival for the patient, it is an image-guided technology that uses heat to destroy cancer cells, effective for pain relief, and has faster recovery. It passes high-frequency electrical currents through the electrode to ground pads placed on the body and helps in the treatment of disease. Thus, increasing cases of cancers around the globe positively impacts the growth of the radiofrequency ablation technology market. Therefore, considering the advantages associated with it, this category is estimated to perform well in the coming years.
Moreover, owing to the developments related to ablation devices, there will be rapid growth observed in the ablation devices market during the forecast period. For instance, in August 2020, Biosense Webster, a subsidiary of Johnson & Johnson Medical Devices Companies, received European CE mark approval for QDOT MICRO radiofrequency ablation catheter. QDOT MICRO treats symptomatic drug-refractory paroxysmal atrial fibrillation and has been designed to deliver high-power ablation in a short amount of time. The device was approved for use in Japan & Europe and was under investigation for U.S. FDA approval.
Therefore, such type of benefits and development activities in the radiofrequency ablation technology segment for ablation devices in the technology type segment would result in driving the demand for ablation devices which in turn would provide a conducive growth environment during the forecast 2024-2030.
North America is expected to dominate the Ablation Devices Market:
Among all the regions, North America is estimated to have the largest revenue share in the global ablation devices market. This can be ascribed to the rising prevalence of cardiac arrhythmias such as atrial fibrillation and the rising regulatory approvals for technologically advanced ablation devices, these factors are expected to aid in the ablation devices market growth during the forecast period from 2024-2030 in the North America market.
One of the key supporting factors for the growth of the North America ablation devices market is the rising prevalence of cardiac arrhythmia such as atrial fibrillation. As per Centers for Disease Control and Prevention (CDC) data published in the year 2023, it was estimated that by the year 2030, there will be 12.1 million cases of atrial fibrillation in the United States. Thus, ablation devices are required to treat people suffering from atrial fibrillation. Therefore, the rising prevalence of cardiac arrhythmia such as atrial fibrillation can increase the demand for ablation devices, thereby contributing to the overall growth of the North America ablation devices market.
Moreover, another factor promoting the market growth of ablation devices in North America is the rising regulatory approvals for technologically advanced ablation devices. For instance, in January 2022, Medtronic, a global leader in medical technology, announced that it has received Food and Drug Administration (FDA) approval in the United States for DiamondTemp(TM) Ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy.
Furthermore, in November 2020, Abbott, a global healthcare leader announced that FDA has cleared the launch of its new device IonicRF(TM) Generator, in the United States, it is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.
Therefore, the interplay of all the factors mentioned above for ablation devices would provide a conducive growth environment for the North American region in the ablation devices market.
Ablation Devices Market Key Players:
Some of the key market players operating in the ablation devices market include Medtronic, AngioDynamics, ATRICURE INC, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, OLYMPUS CORPORATION, Ethicon (Johnson & Johnson Services, Inc), Abbott, CONMED Corporation, Smith & Nephew, BD, Varian Medical Systems Inc, Hologic Inc, Stryker, Japan Lifeline Co Ltd, Merit Medical Systems, Integra LifeSciences, Terumo Europe NV, and others.
Recent Developmental Activities in the Ablation Devices Market:
In December 2022, BD, the largest global medical technology company, announced that it has acquired Venclose, a medical technology company and its solutions for treating chronic venous insufficiency (CVI), such as radio frequency (RF) ablation technology, with its catheters potentially reducing post-operative pain
In July 2020, Ethicon, a part of the Johnson & Johnson Medical Devices Company, announced FDA has granted Breakthrough Device Designation for transbronchial microwave ablation technology using robotic-assisted bronchoscopy in the US, it provides a minimally invasive option for soft tissue lesions.
In February 2019, Medtronic, a global leader in medical technology, launched the new Accurian radiofrequency ablation system in the US, following 510(k) clearance from the country's regulatory authority, radiofrequency ablation involves radio waves-generated current that heats a small portion of nerve tissue to prevent sending of pain signals and thus reduces pain.
Key Takeaways from the Ablation Devices Market Report Study:
Target Audience who can be benefited from this Ablation Devices Market Report Study:
Frequently Asked Questions for Ablation Devices Market:
Ablation systems use heat or cold to cause small burns due to these lesions scar tissues are created that block electrical signals causing arrhythmia. Heat is usually generated by radiofrequency, energy, or laser.
The global ablation devices market is estimated to grow at a CAGR of 11.65% during the forecast period from 2024 to 2030.
Factors such as the increasing incidence of cancers such as liver cancer, the rising prevalence of chronic pains such as musculoskeletal pains, the rising prevalence of cardiac arrhythmia such as atrial fibrillation, and the rising regulatory approvals for technologically advanced ablation devices are further expected to boost the market for ablation devices during the forecast period (2024-2030).
Some of the key market players operating in the Ablation devices market include Medtronic, AngioDynamics, ATRICURE INC, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, OLYMPUS CORPORATION, Ethicon (Johnson & Johnson Services, Inc), Abbott, CONMED Corporation, Smith & Nephew, BD, Varian Medical Systems Inc, Hologic Inc, Stryker, Japan Lifeline Co Ltd, Merit Medical Systems, Integra LifeSciences, Terumo Europe NV, and others.
Among all the regions, North America is estimated to have the largest revenue share in the global ablation devices market. This can be ascribed to the rising prevalence of cardiac arrhythmias such as atrial fibrillation and the rising regulatory approvals for technologically advanced ablation devices, which are expected to aid in the ablation devices market growth in this region.